Bertil Casslén

1.9k total citations
66 papers, 1.6k citations indexed

About

Bertil Casslén is a scholar working on Cancer Research, Immunology and Hematology. According to data from OpenAlex, Bertil Casslén has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 22 papers in Immunology and 21 papers in Hematology. Recurrent topics in Bertil Casslén's work include Protease and Inhibitor Mechanisms (25 papers), Reproductive System and Pregnancy (20 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). Bertil Casslén is often cited by papers focused on Protease and Inhibitor Mechanisms (25 papers), Reproductive System and Pregnancy (20 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). Bertil Casslén collaborates with scholars based in Sweden, Czechia and United States. Bertil Casslén's co-authors include Birger Åstedt, Bo Nilsson, Stefan R. Hansson, Emir Hénic, Gunilla Høyer‐Hansen, Christer Borgfeldt, K. Ohlsson, Anna Ehinger, Roger Wïllén and Zuzana Kolková and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Cancer Research and American Journal of Obstetrics and Gynecology.

In The Last Decade

Bertil Casslén

66 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bertil Casslén Sweden 26 473 473 462 353 322 66 1.6k
Shlomit Goldman Israel 23 534 1.1× 220 0.5× 536 1.2× 366 1.0× 131 0.4× 53 1.6k
Noelle Bersch United States 22 177 0.4× 360 0.8× 304 0.7× 429 1.2× 455 1.4× 41 1.9k
Sarah K. Meadows United States 22 163 0.3× 259 0.5× 605 1.3× 670 1.9× 338 1.0× 36 1.8k
Kimitoshi Imai Japan 21 371 0.8× 131 0.3× 488 1.1× 241 0.7× 46 0.1× 40 1.2k
Koji Aoki Japan 20 310 0.7× 202 0.4× 780 1.7× 947 2.7× 56 0.2× 42 2.1k
Yasushi Saga Japan 22 273 0.6× 251 0.5× 200 0.4× 670 1.9× 82 0.3× 66 1.4k
Abdeljabar El Andaloussi United States 19 162 0.3× 178 0.4× 812 1.8× 540 1.5× 68 0.2× 36 1.7k
Annikki Liakka Finland 16 296 0.6× 171 0.4× 423 0.9× 376 1.1× 43 0.1× 24 1.3k
Margaret L. Flannery United States 11 90 0.2× 303 0.6× 329 0.7× 1.1k 3.0× 125 0.4× 12 1.6k
Helena Stabile Italy 24 154 0.3× 176 0.4× 1.0k 2.3× 529 1.5× 154 0.5× 47 1.8k

Countries citing papers authored by Bertil Casslén

Since Specialization
Citations

This map shows the geographic impact of Bertil Casslén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertil Casslén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertil Casslén more than expected).

Fields of papers citing papers by Bertil Casslén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertil Casslén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertil Casslén. The network helps show where Bertil Casslén may publish in the future.

Co-authorship network of co-authors of Bertil Casslén

This figure shows the co-authorship network connecting the top 25 collaborators of Bertil Casslén. A scholar is included among the top collaborators of Bertil Casslén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertil Casslén. Bertil Casslén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalapotharakos, Grigorios, et al.. (2012). High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer. Journal of Ovarian Research. 5(1). 20–20. 47 indexed citations
2.
Kolková, Zuzana, et al.. (2010). G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua. Molecular Human Reproduction. 16(10). 743–751. 54 indexed citations
3.
Hénic, Emir, et al.. (2009). Estradiol Attenuates EGF-Induced Rapid uPAR Mobilization and Cell Migration via the G-protein-Coupled Receptor 30 in Ovarian Cancer Cells. International Journal of Gynecological Cancer. 19(2). 214–222. 35 indexed citations
4.
Ahmadi, Sara, et al.. (2009). Ovarian cancer cells stimulate uPA gene expression in fibroblastic stromal cells via multiple paracrine and autocrine mechanisms. Gynecologic Oncology. 115(1). 121–126. 21 indexed citations
5.
Hénic, Emir, Christer Borgfeldt, Ib Jarle Christensen, Bertil Casslén, & Gunilla Høyer‐Hansen. (2008). Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian Cancer. Clinical Cancer Research. 14(18). 5785–5793. 64 indexed citations
6.
Casslén, Bertil, et al.. (2008). Monoamine transporters in human endometrium and decidua. Human Reproduction Update. 15(2). 249–260. 15 indexed citations
7.
Skude, G., et al.. (2007). Transvaginal ultrasound and lactate dehydrogenase isoenzyme activity profile in uterine aspirate for diagnosis of endometrial carcinoma in women with postmenopausal bleeding. International Journal of Gynecological Cancer. 17(6). 1322–1326. 4 indexed citations
8.
9.
Hénic, Emir, Michael Sixt, Stefan R. Hansson, Gunilla Høyer‐Hansen, & Bertil Casslén. (2005). EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. Gynecologic Oncology. 101(1). 28–39. 25 indexed citations
10.
11.
Borgfeldt, Christer, Pär‐Ola Bendahl, Mårten Fernö, & Bertil Casslén. (2003). High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer. Gynecologic Oncology. 91(1). 112–117. 11 indexed citations
12.
13.
Casslén, Bertil, et al.. (1998). Discordant expression of mRNA and protein for urokinase and tissue plasminogen activators (u-PA, t-PA) in endometrial carcinoma. International Journal of Cancer. 79(2). 195–201. 12 indexed citations
14.
15.
16.
Casslén, Bertil & M. J. K. Harper. (1991). Human endometrial epithelial cells grown on collagen in serum-free medium. Estrogen responsiveness and morphology. European Journal of Endocrinology. 125(1). 101–108. 7 indexed citations
17.
Casslén, Bertil, et al.. (1991). Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours. European Journal of Cancer and Clinical Oncology. 27(11). 1445–1448. 52 indexed citations
18.
Casslén, Bertil, et al.. (1989). Platelet-Activating Factor in Human Luteal Phase Endometrium1. Biology of Reproduction. 41(4). 578–586. 36 indexed citations
19.
Casslén, Bertil, et al.. (1981). α1‐ANTITRYPSIN — COMPLEXATION AND INACTIVATION IN THE UTERINE FLUID OF IUD‐USERS. Acta Obstetricia Et Gynecologica Scandinavica. 60(2). 103–107. 2 indexed citations
20.
Casslén, Bertil, et al.. (1981). Localization and Quantitation of a Low Molecular Weight Proteinase Inhibitor, Antileukoprotease, in the Human Uterus. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 362(2). 953–962. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shlomit Goldman Breakdown of academic impact, for papers by Noelle Bersch Breakdown of academic impact, for papers by Sarah K. Meadows Breakdown of academic impact, for papers by Kimitoshi Imai Breakdown of academic impact, for papers by Koji Aoki Breakdown of academic impact, for papers by Yasushi Saga Breakdown of academic impact, for papers by Abdeljabar El Andaloussi Breakdown of academic impact, for papers by Annikki Liakka Breakdown of academic impact, for papers by Margaret L. Flannery Breakdown of academic impact, for papers by Helena Stabile
Rankless by CCL
2026